← Leaderboards
Sergei Vakulenko
University Of Notre Dame
$10,048,619
Attributed
$12,324,153
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,324,153 · 6
By mechanism
R01$12,322,439 · 4
P41$1,714 · 2
Top collaborators
- John D Buynak6 shared
Most similar at University Of Notre Dame
Same institution · by research overlap
- Jeffrey W Peng$3,244,235
- Felipe H Santiago$1,756,945
- Seth Blackshaw$26,906,929
- Jeffrey Scott Schorey$5,663,167
Others in their field
Top investigators on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$83,824,814
- Stuart L Schreiber · Harvard University (Medical School)$49,424,554
- Jay D Keasling · University Of California-Berkeley$47,558,861
- David Heimbrook · Leidos Biomedical Research, Inc.$47,513,682
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
EnzymesAntibioticsResistanceDesignBacteriaInfectionAntibiotic ResistanceKineticsMutantApplications GrantsPathogenStructureMolecularGenesComplexEnzyme Inhibitor DrugsInhibitor/AntagonistEvaluationBaseMediatingCarbapenemsEnzymatic BiochemistryAntimicrobialEnzyme Inhibitors
Grant awards (28)
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections$773,298
R01 · FY2025 · AI · contact PI
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections$773,298
R01 · FY2024 · AI · contact PI
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections$773,298
R01 · FY2023 · AI · contact PI
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections$773,154
R01 · FY2022 · AI · contact PI
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections$784,115
R01 · FY2021 · AI · contact PI
Resistance to Carbapenem Antibiotics in Acinetobacter baumannii$673,906
R01 · FY2020 · AI · contact PI
Resistance to Carbapenem Antibiotics in Acinetobacter baumannii$540,927
R01 · FY2019 · AI · contact PI
Resistance to Carbapenem Antibiotics in Acinetobacter baumannii$540,927
R01 · FY2018 · AI · contact PI
Resistance to Carbapenem Antibiotics in Acinetobacter baumannii$540,927
R01 · FY2017 · AI · contact PI
Resistance to Carbapenem Antibiotics in Acinetobacter baumannii$540,927
R01 · FY2016 · AI · contact PI
Class A Carbapenemases$375,000
R01 · FY2015 · AI · contact PI
Aminoglycoside Resistance in Bacteria$375,000
R01 · FY2015 · AI · contact PI
Resistance to Carbapenem Antibiotics in Acinetobacter baumannii$270,464
R01 · FY2015 · AI · contact PI
Aminoglycoside Resistance in Bacteria$375,000
R01 · FY2014 · AI · contact PI
Class A Carbapenemases$375,000
R01 · FY2014 · AI · contact PI
Class A Carbapenemases$352,500
R01 · FY2013 · AI · contact PI
Aminoglycoside Resistance in Bacteria$352,500
R01 · FY2013 · AI · contact PI
Aminoglycoside Resistance in Bacteria$375,000
R01 · FY2012 · AI · contact PI
Class A Carbapenemases$375,000
R01 · FY2012 · AI · contact PI
Aminoglycoside Resistance in Bacteria$369,003
R01 · FY2011 · AI · contact PI
Class A Carbapenemases$362,738
R01 · FY2011 · AI · contact PI
STRUCTURAL STUDIES ON ENZYMES IMPLICATED IN BACTERIAL ANTIBIOTIC RESISTANCE$1,368
P41 · FY2011 · RR · contact PI
Aminoglycoside Resistance in Enterococci$318,272
R01 · FY2010 · AI · contact PI
STRUCTURAL STUDIES ON ENZYMES IMPLICATED IN BACTERIAL ANTIBIOTIC RESISTANCE$346
P41 · FY2010 · RR · contact PI
Aminoglycoside Resistance in Enterococci$321,486
R01 · FY2009 · AI · contact PI
Aminoglycoside Resistance in Enterococci$321,486
R01 · FY2008 · AI · contact PI
Aminoglycoside Resistance in Enterococcus$327,713
R01 · FY2007 · AI · contact PI
Aminoglycoside Resistance in Enterococci$361,500
R01 · FY2006 · AI · contact PI